Das Ende meiner Sucht

Vorab-Veröffentlichung].
    Breslow, M. F., Fankhauser, M. P., Potter, R. L. et al. (1989), Role of gamma-aminobutyric acid in antipanic drug efficacy, American Journal of Psychiatry 146, S. 353–356.
    Colombo, G., Agabio, R., Carai, M. A. et al. (2000), Ability of baclofen in reducing alcohol intake and withdrawal severity: I. Preclinical evidence, Alcoholism: Clinical and Experimental Research 24, S. 58–66.
    Colombo, G., Vacca, G., Serra, S. et al. (2003), Baclofen suppresses motivation to consume alcohol in rats, Psychopharmacology (Berlin) 167, S. 221–224 [elektronische Veröffentlichung am 1. April 2003].
    Davidoff, R. A. (1985), Antispasticity drugs: mechanisms of action, Annals of Neurology 17, S. 107–116.
    Deroche-Gamonet, V., Belin, D. und Piazza, P. V. (2004), Evidence for addiction-like behavior in the rat, Science 305, S. 1014–1017.
    Drake, R. G., Davis, L. L., Cates, M. E. et al. (2003), Baclofen treatment for chronic posttraumatic stress disorder, The Annals of Pharmacotherapy 37, S. 1177–1181.
    Fattore, L., Cossu, G., Martellotta, M. C. et al. (2002), Baclofen antagonizes intravenous self-administration of nicotine in mice and rats, Alcohol and Alcoholism 37, S. 495–498.
    Froehlich, J., O’Malley, S., Hyytia, P. et al. (2003), Preclinical and clinical studies on naltrexone: what have they taught each other?, Alcoholism: Clinical and Experimental Research 27, S. 533–539.
    Gerkin, R., Curry, S. C., Vance, M. V. et al. (1986), First-order elimination kinetics following baclofen overdose, Annals of Emergency Medicine 15, S. 843–846.
    Grant, B. F., Stinson, F. S., Dawson, D. A. et al. (2004), Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions, Archives of General Psychiatry 61, S. 807–816.
    Johnson, B. A., Ait-Daoud, N., Bowden, C. L. et al. (2003), Oral topiramate for treatment of alcohol dependence: a randomized controlled trial, Lancet 361, S. 1677–1685.
    Johnson, B. A., Ait-Daoud, N., Akhtar, F. Z. et al. (2004), Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial, Archives of General Psychiatry 61, S. 905–912.
    Kampman, K. M., Pettinati, H., Lynch, K. G. et al. (2004), A pilot trial of topiramate for the treatment of cocaine dependence, Drug and Alcohol Dependence 75, S. 233–240.
    Kranzler, H. R., Wesson, D. R., Billot, L. et al. (2004), Naltrexone depot for treatment of alcohol dependence: a multicenter, randomized, placebo-controlled clinical trial, Alcoholism: Clinical and Experimental Research 28, S. 1051–1059.
    Krupitsky, E. M., Burakov, A. M., Ivanov, V. B. et al. (1993), Baclofen administration for the treatment of affective disorders in alcoholic patients, Drug and Alcohol Dependence 33, S. 157–163.
    Morse, R. M. und Flavin, D. K. (1992), The definition of alcoholism. The Joint Committee of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism, The Journal of the American Medical Association 268, S. 1012–1014.
    Nemeroff, C. B. (2003), The role of GABA in the pathophysiology and treatment of anxiety disorders, Psychopharmacological Bulletin 37, S. 133–146.
    Nielsen, J. F., Hansen, H. J., Sunde, N. et al. (2002), Evidence of tolerance to baclofen in treatment of severe spasticity with intrathecal baclofen, Clinical Neurology and Neurosurgery 104, S. 142–145.
    Pelc, I., Ansoms, C., Lehert, P. et al. (2002), The European NEAT program: an integrated approach using acamprosate and psychosocial support for the prevention of relapse in alcohol-dependent patients with a statistical modeling of therapy success prediction, Alcoholism: Clinical and Experimental Research 26, S. 1529–1538.
    Roberts, D. C. und Andrews, M. M. (1997), Baclofen suppression of cocaine self-administration: demonstration using a discrete trials procedure, Psychopharmacology (Berlin) 131, S. 271–277.
    Shoaib, M., Swanner, L. S., Beyer, C. E. et al. (1998), The GABA B agonist baclofen modifies cocaine self-administration in rats, Behavioral Pharmacology 9, S. 195–206.
    Shoptaw, S., Yang, X., Rotheram-Fuller, E. J. et al. (2003), Randomized placebo-controlled trial of baclofen for cocaine dependence: preliminary effects for individuals with chronic